Meeting
2022 ASCO Annual Meeting
Thromboembolism (TE) and association with survival in patients (pts) with melanoma receiving chemo– or immunotherapy.
Authors
Tamara A. Sussman
Dana-Farber Cancer Institute, Boston, MA
Tamara A. Sussman , Long Vu , Elizabeth Iannotti Buchbinder , Patrick Alexander Ott , Sarah C. Markt , Siran M. Koroukian , F. Stephen Hodi , Alok A. Khorana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 12082)
DOI
10.1200/JCO.2022.40.16_suppl.12082
Abstract #
12082
Poster Bd #
328
Abstract Disclosures
Similar Posters
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Venous thromboembolism (VTE) in melanoma patients (pts) on immunotherapy (IO).
First Author: Tamara A. Sussman
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2020 ASCO Virtual Scientific Program
Computerized features of spatial arrangement of tumor-infiltrating lymphocytes from H&E images predicts survival and response to checkpoint inhibitors in gynecologic cancers.
First Author: Sepideh Azarianpour Esfahani
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience.
First Author: Karim Welaya